Kawashima Osamu, Ibe Takashi, Kakegawa Seiichi, Nakano Tetsuhiro, Shimizu Kimihiro
Osamu Kawashima, Department of Chest Surgery, Nishi-Gunma Hospital, Shibukawa, Japan.
Kyobu Geka. 2010 Oct;63(11):935-9.
From 2000 to 2009, we retrospectively reviewed 62 patients who underwent surgical treatment for postoperative recurrent or 2nd primary lung cancer. Of the 62 patients, 43 were men and 19 were women with an average age of 67.6 years old. The histology of the initial primary lung cancer was adenocarcinoma in 42 patients, squamous cell carcinoma in 18, large cell carcinoma in 1 and small cell carcinoma in 1. The surgical procedures for 1st operation were lobectomy with mediastinal lymph node dissection in 52, bilobectomy with mediastinal lymph node dissection in 4, sleeve lobectomy with mediastinal lymph node dissection in 3, and lobectomy + segmentectomy or wedge resection with mediastinal lymph node dissection in 3. p-stage of the 1st primary lung cancer was IA in 22, IB in 16, II A in 7, IIB in 6, IIIA in 6, IIIB in 4, and IV in 1. On the 2nd operation, 56 patients underwent limited surgery. Five patients underwent a lobectomy twice metachronous bilateral lesions and 1 patient underwent completion pneumonectomy (CP) at the 2nd operation. The average age at 2nd operation was 71.8 years old. Of these, 42 patients were diagnosed 2nd primary lung cancer, 20 patients were recurrent disease histologically. The 5-year survival rate of the patients with metachronous and recurrent disease from the 2nd operation was 54.1%, and 43.1%, respectively. Although lobectomy or CP should be considered the surgical procedure of choice for patients with metachronous lung cancer, with this result, we consider that postoperative good survival can be expected by even the limited operation for cases of postoperative recurrent or 2nd primary lung cancer because of possible early detection. We conclude that limited surgery may be a treatment of choice for recurrent or 2nd primary lung cancer after initial operation.
2000年至2009年,我们回顾性分析了62例接受手术治疗的术后复发性或第二原发性肺癌患者。62例患者中,男性43例,女性19例,平均年龄67.6岁。初始原发性肺癌的组织学类型为腺癌42例,鳞状细胞癌18例,大细胞癌1例,小细胞癌1例。首次手术的术式为肺叶切除加纵隔淋巴结清扫52例,双肺叶切除加纵隔淋巴结清扫4例,袖状肺叶切除加纵隔淋巴结清扫3例,肺叶切除+段切除或楔形切除加纵隔淋巴结清扫3例。首次原发性肺癌的p分期为IA期22例,IB期16例,IIA期7例,IIB期6例,IIIA期6例,IIIB期4例,IV期1例。第二次手术时,56例患者接受了局限性手术。5例患者因异时性双侧病变接受了两次肺叶切除术,1例患者在第二次手术时接受了全肺切除术(CP)。第二次手术时的平均年龄为71.8岁。其中,42例患者被诊断为第二原发性肺癌,20例患者为复发性疾病。第二次手术后异时性和复发性疾病患者的5年生存率分别为54.1%和43.1%。虽然肺叶切除或CP应被视为异时性肺癌患者的首选手术方式,但基于此结果,我们认为,由于可能实现早期发现,对于术后复发性或第二原发性肺癌患者,即使是局限性手术也有望获得良好的术后生存率。我们得出结论,局限性手术可能是初次手术后复发性或第二原发性肺癌的一种治疗选择。